Jenny Petering and other members of the BioMelbourne Network have responded positively to the Australian Government's recently announced National Science & Innovation Agenda.
"It is particularly pleasing to see the tax incentives for early stage investors. Hopefully these incentives will stimulate financing of biotech start-ups. Much is still to be done however in terms of developing IP and commercialisation strategies in order to generate real value from these investments," says Jenny.
Hear what others have said of the Agenda and its impact on Australia and, specifically, the biotechnology industry over on LinkedIn.